Traphaco JSC (HOSE:TRA)

Market Cap	2.95T -7.4%
Revenue (ttm)	2.65T +13.0%
Net Income	216.50B +4.5%
EPS	5,222.99 +4.7%
Shares Out	41.45M
PE Ratio	13.63
Forward PE	n/a
Dividend	4,000.00 (5.57%)
Ex-Dividend Date	Dec 31, 2025

Volume	83,612
Average Volume	12,104
Open	71,800
Previous Close	71,800
Day's Range	71,000 - 71,800
52-Week Range	63,000 - 79,000
Beta	0.07
RSI	41.81
Earnings Date	Jan 30, 2026

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,670
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2025, Traphaco JSC's revenue was 2.65 trillion, an increase of 12.98% compared to the previous year's 2.35 trillion. Earnings were 216.50 billion, an increase of 4.67%.